Authors:
SCHUMACHER M
HALWACHS G
TATZBER F
FRUHWALD FM
ZWEIKER R
WATZINGER N
EBER B
WILDERSTRUSCHNIG M
ESTERBAUER H
KLEIN W
Citation: M. Schumacher et al., INCREASED NEOPTERIN IN PATIENTS WITH CHRONIC AND ACUTE CORONARY SYNDROMES, Journal of the American College of Cardiology, 30(3), 1997, pp. 703-707
Authors:
HALWACHS G
IBERER F
PIEBER T
MULLER H
TSCHELIESSNIGG K
TIRAN A
SABIN K
WILDERSTRUSCHNIG M
Citation: G. Halwachs et al., TROPONIN-T AS A MARKER FOR POSTTRANSPLANTATION ADAPTATIONAL PROBLEMS OF THE DONOR HEART, The Journal of heart and lung transplantation, 15(5), 1996, pp. 451-455
Authors:
IBERER F
TSCHELIESSNIGG K
HALWACHS G
AUER T
WASLER A
PETUTSCHNIGG B
SCHREIER G
MULLER H
ALLMAYR T
PRENNER G
HIPMAIR G
GRASSER B
FREIGASSNER M
Citation: F. Iberer et al., CYTOMEGALOVIRUS ANTIGENEMIA AS A MARKER FOR ANTIVIRAL THERAPY AFTER HEART-TRANSPLANTATION, The Journal of heart and lung transplantation, 15(3), 1996, pp. 314-315
Authors:
HUBER PR
BISCHOF P
KRETSCHMER R
TRUSCHNIG M
HALWACHS G
SCHMIDT M
Citation: Pr. Huber et al., CA-15-3 - A MULTICENTER EVALUATION OF AUTOMATED AND MANUAL TESTS, European journal of clinical chemistry and clinical biochemistry, 34(1), 1996, pp. 77-84
Authors:
IBERER F
TSCHELIESSNIGG K
HALWACHS G
REHAK P
WASLER A
PETUTSCHNIGG B
SCHREIER G
MULLER H
ALLMAYER T
FREIGASSNER M
PRENNER G
HIPMAIR G
GRASSER B
Citation: F. Iberer et al., DEFINITIONS OF CYTOMEGALOVIRUS DISEASE AFTER HEART-TRANSPLANTATION - ANTIGENEMIA AS A MARKER FOR ANTIVIRAL THERAPY, Transplant international, 9(3), 1996, pp. 236-242
Authors:
STAUBER RE
VOLLMANN H
PESSERL I
JAUK B
LIPP R
HALWACHS G
WILDERSTRUSCHNIG M
Citation: Re. Stauber et al., CARBOHYDRATE-DEFICIENT TRANSFERRIN IN HEALTHY WOMEN - RELATION TO ESTROGENS AND IRON STATUS, Alcoholism, clinical and experimental research, 20(6), 1996, pp. 1114-1117
Authors:
REISINGER E
WENDELIN I
GASSER R
HALWACHS G
WILDERSTRUSCHNIG M
KREJS G
Citation: E. Reisinger et al., ANTIBIOTICS AND INCREASED TEMPERATURE AGAINST BORRELIA-BURGDORFERI IN-VITRO, Scandinavian journal of infectious diseases, 28(2), 1996, pp. 155-157
Authors:
SCHUMACHER M
EBER B
TATZBER F
KAUFMANN P
HALWACHS G
FRUHWALD FM
ZWEIKER R
ESTERBAUER H
KLEIN W
Citation: M. Schumacher et al., TRANSIENT REDUCTION OF AUTOANTIBODIES AGAINST OXIDIZED LDL IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION, Free radical biology & medicine, 18(6), 1995, pp. 1087-1091
Authors:
IBERER F
TSCHELIESSNIGG KH
HALWACHS G
AUER T
WASLER A
PETUTSCHNIGG B
MULLER H
FREIGASSNER M
ALLMAYR T
HIPMAIR G
PRENNER G
GRASSER B
Citation: F. Iberer et al., CMV ANTIGENEMIA (THE LOWER MATRIX PROTEIN PP65), A MARKER FOR THE GUIDANCE OF ANTIVIRAL THERAPY IN CYTOMEGALOVIRUS DISEASE AFTER ORTHOTOPICHEART-TRANSPLANTATION, Wiener Klinische Wochenschrift, 107(23), 1995, pp. 718-722
Authors:
IBERER F
TSCHELIESSNIGG K
HALWACHS G
AUER T
WASLER A
PETUTSCHNIGG B
SCHREIER G
MULLER H
ALLMAYER T
PRENNER G
HIPPMAIR G
GRASSER B
FREIGASSNER M
Citation: F. Iberer et al., CYTOMEGALOVIRUS AFTER HEART-TRANSPLANTATION - DEFINITIONS FOR THE GUIDANCE OF ANTIVIRAL THERAPY, Scandinavian journal of infectious diseases, 1995, pp. 100-103
Authors:
SCHUMACHER M
EBER B
HALWACHS G
FRUHWALD FM
ZWEIKER R
POKAN R
WILDERSTRUSCHNIG M
KLEIN W
Citation: M. Schumacher et al., DEPENDENCE OF SOLUBLE TUMOR-NECROSIS-FACTOR RECEPTOR-1 AND RECEPTOR-2VALUES ON THE SEVERITY AND DURATION OF ISCHEMIC-HEART-DISEASE, Circulation, 92(11), 1995, pp. 3362-3362
Authors:
HALWACHS G
TIRAN A
REISINGER EC
ZACH R
SABIN K
FOLSCH B
LANZER H
HOLZER H
WILDERSTRUSCHNIG M
Citation: G. Halwachs et al., SERUM LEVELS OF THE SOLUBLE RECEPTOR FOR TUMOR-NECROSIS-FACTOR IN PATIENTS WITH RENAL-DISEASE, The Clinical investigator, 72(6), 1994, pp. 473-476
Authors:
HALWACHS G
ZACH R
POGGLITSCH H
HOLZER H
TIRAN A
IBERER F
WASLER A
TSCHELIESSNIGG HP
LANZER G
FOLSCH B
WILDERSTRUSCHNIG M
Citation: G. Halwachs et al., A RAPID IMMUNOCYTOCHEMICAL ASSAY FOR CMV DETECTION IN PERIPHERAL-BLOOD OF ORGAN-TRANSPLANTED PATIENTS IN CLINICAL-PRACTICE, Transplantation, 56(2), 1993, pp. 338-342